Tapewire

Nasdaq · USD

AURA

Aura Biosciences, Inc.

Export transactions ↓
Tapewire entity
5142
SEC CIK
0001501796
Parsed reports
136

Last 12 months

Inside the activity.

0 purchase rows · 11 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 202500
Jan 202602
Feb 202605
Mar 202600
Apr 202601
May 202601
Jun 202601
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 21, 2025 Filed Jan 21, 2025 21:09 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 15,955 $7.67 $122,381.23
Disclosure

SEC source: 0000950170-25-007495 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 304,692

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.67 to $7.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 18, 2024 Filed Nov 19, 2024 02:06 UTC
Hopkins Janet JillChief Medical Officer
SaleCommon Stock 11,822 $9.36 $110,663.38
Disclosure

SEC source: 0000950170-24-128206 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 151,693

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.36 to $9.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 29, 2024 Filed Oct 30, 2024 00:23 UTC
Elazzouzi AmyVice President, Finance
SaleCommon Stock 553 $10.74 $5,938.39
Disclosure

SEC source: 0000950170-24-118475 · ownership.xml · nonDerivative · entry 1

Elazzouzi Amy · CIK 0002042910 · Vice President, Finance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,443

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.65 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 29, 2024 Filed Oct 29, 2024 20:28 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 9,200 $10.74 $98,787.76
Disclosure

SEC source: 0000950170-24-118478 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,647

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.61 to $10.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 20:08 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 24,992 $0.00 Strike: $2.74 $0.00
Disclosure

SEC source: 0000950170-24-115729 · ownership.xml · derivative · entry 4

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 336,171

Underlying: Common Stock · 24,992 shares

Expires 2028-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.

F4 · derivative.exercise_date: This option is fully vested.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 20:08 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 24,992 $12.04 $300,838.70
Disclosure

SEC source: 0000950170-24-115729 · ownership.xml · nonDerivative · entry 2

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 329,847

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 18, 2024 Filed Oct 18, 2024 20:08 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionCommon Stock 24,992 $2.74 $68,478.08
Disclosure

SEC source: 0000950170-24-115729 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 354,839

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $5.48 $0.00
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · derivative · entry 7

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 120,547

Underlying: Common Stock · 5,000 shares

Expires 2031-06-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

F4 · derivative.exercise_date: The shares underlying this option vest in 48 monthly installments, equal to 2.0833% of the shares, over the 48 months following June 28, 2021.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,631 $0.00 Strike: $4.25 $0.00
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · derivative · entry 6

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 32,359

Underlying: Common Stock · 2,631 shares

Expires 2030-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 17,500 $0.00 Strike: $2.74 $0.00
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · derivative · entry 5

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 68,257

Underlying: Common Stock · 17,500 shares

Expires 2028-10-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
SaleCommon Stock 25,131 $12.03 $302,361.11
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · nonDerivative · entry 4

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 134,276

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.0000 to $12.3000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
Exercise / conversionCommon Stock 5,000 $5.48 $27,400.00
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · nonDerivative · entry 3

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159,407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
Exercise / conversionCommon Stock 2,631 $4.25 $11,181.75
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · nonDerivative · entry 2

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 154,407

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

Read SEC document
October 18, 2024 Filed Oct 21, 2024 22:23 UTC
Feder Julie BChief Financial Officer
Exercise / conversionCommon Stock 17,500 $2.74 $47,950.00
Disclosure

SEC source: 0000950170-24-116029 · ownership.xml · nonDerivative · entry 1

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,776

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

Read SEC document
October 16, 2024 Filed Oct 17, 2024 01:25 UTC
Plavsic MarkChief Technology Officer
SaleCommon Stock 7,383 $9.85 $72,722.55
Disclosure

SEC source: 0000950170-24-115150 · ownership.xml · nonDerivative · entry 1

Plavsic Mark · CIK 0001868719 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 121,132

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a sell to cover transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
September 27, 2024 Filed Oct 1, 2024 17:08 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 5,474 $0.00 Strike: $5.76 $0.00
Disclosure

SEC source: 0000950170-24-110933 · ownership.xml · derivative · entry 3

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,474 shares

Expires 2024-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On September 27, 2024, the Reporting Person exercised long held stock options to purchase 5,474 shares of the Issuer's common stock, as they were set to expire on October 1, 2024.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
September 27, 2024 Filed Oct 1, 2024 17:08 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionCommon Stock 5,474 $5.76 $31,530.24
Disclosure

SEC source: 0000950170-24-110933 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,847

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: On September 27, 2024, the Reporting Person exercised long held stock options to purchase 5,474 shares of the Issuer's common stock, as they were set to expire on October 1, 2024.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 20:05 UTC GrantStock Option (Right to Buy) · Derivative 14,500 $0.00 Strike: $6.93 $0.00
Disclosure

SEC source: 0000950170-24-076707 · ownership.xml · derivative · entry 5

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,500

Underlying: Common Stock · 14,500 shares

Expires 2034-06-20

F5 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 20:05 UTC GrantCommon Stock 10,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-076707 · ownership.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,167

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 20:09 UTC GrantStock Option (Right to Buy) · Derivative 14,500 $0.00 Strike: $6.93 $0.00
Disclosure

SEC source: 0000950170-24-076715 · ownership.xml · derivative · entry 2

Mattessich Antony C. · CIK 0001709900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,500

Underlying: Common Stock · 14,500 shares

Expires 2034-06-20

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 20:09 UTC GrantCommon Stock 10,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-076715 · ownership.xml · nonDerivative · entry 1

Mattessich Antony C. · CIK 0001709900 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 20:08 UTC GrantStock Option (Right to Buy) · Derivative 14,500 $0.00 Strike: $6.93 $0.00
Disclosure

SEC source: 0000950170-24-076713 · ownership.xml · derivative · entry 2

Srivastava Sapna · CIK 0001569226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,500

Underlying: Common Stock · 14,500 shares

Expires 2034-06-20

F2 · derivative.exercise_date: This stock option will vest and become exercisable in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
June 20, 2024 Filed Jun 24, 2024 20:08 UTC GrantCommon Stock 10,500 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-076713 · ownership.xml · nonDerivative · entry 1

Srivastava Sapna · CIK 0001569226 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,500

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in full upon the earlier to occur of (a) June 20, 2025 or (b) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service as of such vesting date.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 20:10 UTC
Kilroy ConorGeneral Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 144,000 $0.00 Strike: $7.40 $0.00
Disclosure

SEC source: 0000950170-24-041803 · ownership.xml · derivative · entry 2

Kilroy Conor · CIK 0001808510 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,000

Underlying: Common Stock · 144,000 shares

Expires 2034-04-01

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on April 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
April 02, 2024 Filed Apr 4, 2024 20:10 UTC
Kilroy ConorGeneral Counsel and Secretary
GrantCommon Stock 96,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-041803 · ownership.xml · nonDerivative · entry 1

Kilroy Conor · CIK 0001808510 · General Counsel and Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 96,000

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on April 15, 2025, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 16:01 UTC
de los Pinos ElisabetDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 237,065 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0000950170-24-010460 · ownership.xml · derivative · entry 3

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 237,065

Underlying: Common Stock · 237,065 shares

Expires 2034-01-31

F3 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 16:01 UTC
de los Pinos ElisabetDirector · See Remarks
GrantCommon Stock 162,935 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010460 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 324,373

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2025, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:01 UTC
Hopkins Janet JillChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 41,485 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0000950170-24-010461 · ownership.xml · derivative · entry 2

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,485

Underlying: Common Stock · 41,485 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:01 UTC
Hopkins Janet JillChief Medical Officer
GrantCommon Stock 28,515 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010461 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,515

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2025, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:01 UTC
Feder Julie BChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 103,715 $0.00 Strike: $7.77 $0.00
Disclosure

SEC source: 0000950170-24-010462 · ownership.xml · derivative · entry 2

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 103,715

Underlying: Common Stock · 103,715 shares

Expires 2034-01-31

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on February 1, 2025 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
February 01, 2024 Filed Feb 2, 2024 21:01 UTC
Feder Julie BChief Financial Officer
GrantCommon Stock 71,285 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-010462 · ownership.xml · nonDerivative · entry 1

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,276

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2025, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
January 23, 2024 Filed Jan 24, 2024 16:20 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 15,853 $7.64 $121,140.70
Disclosure

SEC source: 0000950170-24-006988 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,438

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.6758, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
January 23, 2024 Filed Jan 24, 2024 21:18 UTC
Feder Julie BChief Financial Officer
SaleCommon Stock 6,609 $7.64 $50,521.18
Disclosure

SEC source: 0000950170-24-006987 · ownership.xml · nonDerivative · entry 1

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,991

F1 · kind: The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:35 UTC
GOEL DAVID E.10% owner
PurchaseCommon Stock, par value $0.00001 per share (Common Stock) 1,560,000 $9.00 $14,040,000.00
Disclosure

SEC source: 0000902664-23-005429 · ownership.xml · nonDerivative · entry 1

Matrix Capital Management Company, LP · CIK 0001410830 · 10% owner

GOEL DAVID E. · CIK 0001548144 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnotes

Disclosed balance after: 6,922,870

F1 · ownership.nature: The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager.

F2 · ownership.nature: The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.

Read SEC document
November 08, 2023 Filed Nov 9, 2023 22:02 UTC PurchaseCommon Stock 10,000 $7.30 $73,000.00
Disclosure

SEC source: 0000950170-23-062214 · ownership.xml · nonDerivative · entry 6

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By NEJ12 IRREVOCABLE TRUST

Disclosed balance after: 75,000

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $7.22 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.

Read SEC document
November 08, 2023 Filed Nov 9, 2023 22:02 UTC PurchaseCommon Stock 10,000 $7.30 $73,000.00
Disclosure

SEC source: 0000950170-23-062214 · ownership.xml · nonDerivative · entry 5

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By NEJ09 IRREVOCABLE TRUST

Disclosed balance after: 75,000

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $7.22 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F2 · ownership.nature: The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.

Read SEC document
November 08, 2023 Filed Nov 9, 2023 22:02 UTC PurchaseCommon Stock 9,601 $7.30 $70,087.30
Disclosure

SEC source: 0000950170-23-062214 · ownership.xml · nonDerivative · entry 4

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,667

F4 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $7.22 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
November 07, 2023 Filed Nov 9, 2023 22:02 UTC PurchaseCommon Stock 47,000 $7.17 $336,990.00
Disclosure

SEC source: 0000950170-23-062214 · ownership.xml · nonDerivative · entry 3

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By NEJ09 IRREVOCABLE TRUST

Disclosed balance after: 65,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $6.50 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F3 · ownership.nature: The shares are held by the NEJ12 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.

Read SEC document
November 07, 2023 Filed Nov 9, 2023 22:02 UTC PurchaseCommon Stock 47,000 $7.17 $336,990.00
Disclosure

SEC source: 0000950170-23-062214 · ownership.xml · nonDerivative · entry 2

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · By NEJ09 IRREVOCABLE TRUST

Disclosed balance after: 65,000

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $6.50 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

F2 · ownership.nature: The shares are held by the NEJ09 IRREVOCABLE TRUST dated December 24, 2020, of which the Reporting Person is a trustee.

Read SEC document
November 07, 2023 Filed Nov 9, 2023 22:02 UTC PurchaseCommon Stock 76,000 $7.17 $544,920.00
Disclosure

SEC source: 0000950170-23-062214 · ownership.xml · nonDerivative · entry 1

Johnson David Michael · CIK 0001808098 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,066

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions in prices ranging from $6.50 to $7.42, inclusive. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
November 06, 2023 Filed Nov 7, 2023 18:19 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionStock Option (Right to Buy) · Derivative 3,800 $0.00 Strike: $2.74 $0.00
Disclosure

SEC source: 0000950170-23-060499 · ownership.xml · derivative · entry 4

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 361,163

Underlying: Common Stock · 3,800 shares

Expires 2028-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.

F4 · derivative.exercise_date: This option is fully vested.

Read SEC document
November 06, 2023 Filed Nov 7, 2023 18:19 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 7,449 $12.03 $89,610.73
Disclosure

SEC source: 0000950170-23-060499 · ownership.xml · nonDerivative · entry 2

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 177,291

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.13, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 06, 2023 Filed Nov 7, 2023 18:19 UTC
de los Pinos ElisabetDirector · See Remarks
Exercise / conversionCommon Stock 3,800 $2.74 $10,412.00
Disclosure

SEC source: 0000950170-23-060499 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 184,740

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 22, 2023 previously adopted by the reporting person.

Read SEC document
November 06, 2023 Filed Nov 7, 2023 23:09 UTC
Feder Julie BChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 3,900 $0.00 Strike: $2.74 $0.00
Disclosure

SEC source: 0000950170-23-060493 · ownership.xml · derivative · entry 3

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 85,757

Underlying: Common Stock · 3,900 shares

Expires 2028-10-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

F3 · derivative.exercise_date: This option is fully vested.

Read SEC document
November 06, 2023 Filed Nov 7, 2023 23:09 UTC
Feder Julie BChief Financial Officer
SaleCommon Stock 3,900 $12.07 $47,053.89
Disclosure

SEC source: 0000950170-23-060493 · ownership.xml · nonDerivative · entry 2

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 69,600

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
November 06, 2023 Filed Nov 7, 2023 23:09 UTC
Feder Julie BChief Financial Officer
Exercise / conversionCommon Stock 3,900 $2.74 $10,686.00
Disclosure

SEC source: 0000950170-23-060493 · ownership.xml · nonDerivative · entry 1

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 73,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated June 23, 2023 previously adopted by the reporting person.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:04 UTC
Hopkins Janet JillChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 200,000 $0.00 Strike: $8.97 $0.00
Disclosure

SEC source: 0000950170-23-058900 · ownership.xml · derivative · entry 2

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2033-10-31

F2 · derivative.exercise_date: The shares underlying this option vest as follows: 25% of the shares vest on October 16, 2024 with the remainder vesting thereafter in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
November 01, 2023 Filed Nov 3, 2023 21:04 UTC
Hopkins Janet JillChief Medical Officer
GrantCommon Stock 135,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-23-058900 · ownership.xml · nonDerivative · entry 1

Hopkins Janet Jill · CIK 0001997710 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 135,000

F1 · shares: These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Company's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Company's common stock. These RSUs vest in four substantially equal annual installments beginning on November 15, 2024, subject to the Reporting Person's continued service as of each such vesting date.

Read SEC document
October 30, 2023 Filed Nov 1, 2023 18:21 UTC
de los Pinos ElisabetDirector · See Remarks
SaleCommon Stock 9,586 $6.83 $65,478.13
Disclosure

SEC source: 0000950170-23-057640 · ownership.xml · nonDerivative · entry 1

de los Pinos Elisabet · CIK 0001889633 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,940

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.345, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
October 30, 2023 Filed Nov 1, 2023 22:24 UTC
Feder Julie BChief Financial Officer
SaleCommon Stock 3,385 $6.82 $23,090.78
Disclosure

SEC source: 0000950170-23-057643 · ownership.xml · nonDerivative · entry 1

Feder Julie B · CIK 0001710237 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,600

F1 · kind: The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.80 to $7.1822, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.